0001755876-25-000001.txt : 20250106
0001755876-25-000001.hdr.sgml : 20250106
20250106130022
ACCESSION NUMBER: 0001755876-25-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20250106
DATE AS OF CHANGE: 20250106
EFFECTIVENESS DATE: 20250106
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Epicore Biosystems, Inc.
CENTRAL INDEX KEY: 0001755876
ORGANIZATION NAME:
IRS NUMBER: 821356381
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-534274
FILM NUMBER: 25510139
BUSINESS ADDRESS:
STREET 1: 485 MASSACHUSETTS AVENUE
STREET 2: SUITE 324
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 8575297776
MAIL ADDRESS:
STREET 1: 485 MASSACHUSETTS AVENUE
STREET 2: SUITE 324
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
D
1
primary_doc.xml
X0708
D
LIVE
0001755876
Epicore Biosystems, Inc.
810 Memorial Drive
SUITE 100
CAMBRIDGE
MA
MASSACHUSETTS
02139
6172513686
DELAWARE
None
None
Corporation
true
Roozbeh
Ghaffari
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
John
Rogers
810
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Director
Laura
Lang
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Director
Kimberly
Querrey
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Director
Stephen
Lee
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
John
Wright
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Alexander
J.
Aranyosi
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
James
Ryan
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Jeffrey
Model
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Weihua
Li
810 Memorial Drive
Suite 100
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-12-11
false
true
false
0
35000000
25686104
9313896
false
44
0
0
0
false
Epicore Biosystems, Inc.
Roozbeh Ghaffari
Roozbeh Ghaffari
CEO
2025-01-06